Document is current
Any future updates will be listed below
-
Authors
Eghbali, Aziz https://orcid.org/0000-0002-5118-0094
Adibifar, Mahsa https://orcid.org/0009-0006-7117-8000
Ghasemi, Ali https://orcid.org/0000-0002-4996-7656
Afzal, Roghayeh Rahimi https://orcid.org/0000-0003-4000-8798
Moradi, Katayoun https://orcid.org/0000-0001-8787-3776
Eghbali, Aygin https://orcid.org/0000-0002-6670-2270
Faress, Foroozan https://orcid.org/0000-0002-5057-6388
Ghaffari, Kazem https://orcid.org/0000-0002-6077-3123
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 17 February 2025
First Online: 25 February 2025
Change Date: 5 August 2025
Change Type: Update
Change Details: The original article has been updated: Affiliation 6 is updated to Neuromusculoskeletal Research Center, Department of Physical Medicine and Rehabilitation, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Declarations
:
: The local ethics committee of the Iran University of Medical Sciences approved the research protocol by the ethical code IR.IUMS.FMD.REC.1401.313. The trial was registered at the Registry of Clinical Trials as IRCT20201107049296N3, First Trial Registration: 11/09/2022, Access: ) and according to the CONSORT. reporting guidelines. By the Helsinki Convention, and after obtaining informed consent from the patients (informed consent was obtained from parents for patients under the age of consent and from the patients themselves for those over the age of consent), the patients were included in the study. A safety committee that operates autonomously receives annual updates regarding the progress of the study, the occurrence of severe adverse events, and their characteristics. This committee concluded that there were no reasonable grounds to terminate the study.
: Not applicable.
: The authors declare no competing interests.
